首页> 外文期刊>Analytical chemistry >High Resolution CZE-MS Quantitative Characterization of Intact Biopharmaceutical Proteins: Proteoforms of Interferon-beta 1
【24h】

High Resolution CZE-MS Quantitative Characterization of Intact Biopharmaceutical Proteins: Proteoforms of Interferon-beta 1

机译:完整的生物制药蛋白的高分辨率CZE-MS定量表征:干扰素-β1的蛋白形式。

获取原文
获取原文并翻译 | 示例
       

摘要

New and improved methods are required for the enhanced characterization of complex biopharmaceuticals, especially those with charge and glycan heterogeneity. High resolution separation and mass spectrometry (MS) analysis of intact proteoforms can contribute significantly to the characterization of such proteins, many of which are glycoproteins. Here, we report on capillary zone electrophoresis (CZE) coupled via a commercial CESI sheathless interface to an Orbitrap ELITE MS for the intact analysis of recombinant human interferon-beta 1 (Avonex, rhIFN-beta 1), a biopharmaceutical with complex glycosylation at a single N-linked site. Using a cross-linked polyethylenimine coating, column efficiencies between 350,000 and 450,000 plates were produced, allowing separation based on charge and subtle hydrodynamic volume differences. A total of 138 proteoforms were found, and 55 were quantitated. Charge species due to deamidation and sialylation were separated by CZE. Given the high column efficiency, isobaric positional isomers of a single sialic acid on biantennary glycan antennae were resolved. Further, triantennary isomers (antenna on a(1-3) or a(1-6) arms) were separated and confirmed by exoglycosidase digestion. Proteoforms of the N-terminal cleavage of methionine were detected by precursor molecular weight and top-down ETD and HCD analysis of the reduced protein. Quantitative analysis suggested potential correlations between the methionine loss with the relative amount of the deamidation, as well as the level of deamidation with glycan structure. We demonstrate that high resolution CZE separation of intact glycoprotein species coupled to MS has significant potential for the in-depth characterization and quantitative analysis of biopharmaceutical proteoforms.
机译:需要新的和改进的方法来增强复杂生物药物尤其是具有电荷和聚糖异质性的生物药物的表征。完整蛋白体的高分辨率分离和质谱(MS)分析可以显着促进此类蛋白的表征,其中许多蛋白都是糖蛋白。在这里,我们报告通过商业CESI无鞘接口耦合到Orbitrap ELITE MS的毛细管区带电泳(CZE),以完整分析重组人干扰素-β1(Avonex,rhIFN-β1),这是一种具有复杂糖基化作用的生物药物。单个N链接站点。使用交联的聚乙烯亚胺涂层,色谱柱的柱效在350,000和450,000之间,可根据装料量和细微的流体动力学体积差异进行分离。总共发现了138种蛋白形式,并定量了55种。用CZE分离由于脱酰胺和唾液酸化引起的电荷种类。考虑到高的柱效,解决了双触角聚糖触角上单个唾液酸的同量异位异构体。此外,分离三触角异构体(a(1-3)或a(1-6)臂上的天线),并通过糖苷外切酶消化进行确认。通过前体分子量和自上而下的ETD和还原蛋白的HCD分析检测蛋氨酸N末端裂解的蛋白形式。定量分析表明蛋氨酸损失与脱酰胺的相对量以及聚糖结构的脱酰胺水平之间存在潜在的相关性。我们证明完整的糖蛋白种类与MS的高分辨率CZE分离对生物制药蛋白的深入表征和定量分析具有重大潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号